These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The need for health care reform. Mossinghoff GJ Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516 [No Abstract] [Full Text] [Related]
4. Can price and regulatory controls replace free market competition in the drug industry? Buc NL; Levitt GM Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839 [No Abstract] [Full Text] [Related]
5. Health care reform's price fight. Stone PH Natl J (Wash); 1994 Aug; 26(33):1923-4. PubMed ID: 10139263 [No Abstract] [Full Text] [Related]
6. Price controls in the pharmaceutical industry could hurt medical education. Hull AR Nephrol News Issues; 1993 Jun; 7(6):46-7. PubMed ID: 8133929 [No Abstract] [Full Text] [Related]
7. Opinion: price controls on prescription drugs. Franks B N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791 [No Abstract] [Full Text] [Related]
8. Studies renew price-curb talk. Weissenstein E Mod Healthc; 1994 Feb; 24(6):17. PubMed ID: 10131519 [No Abstract] [Full Text] [Related]
9. Drug price controls will cripple research and development, pharmaceutical executives tell Congress. Am J Hosp Pharm; 1994 May; 51(9):1132, 1135-6, 1139. PubMed ID: 8042629 [No Abstract] [Full Text] [Related]
10. Healthcare update ... debate over discounted drug prices. Scott L Mod Healthc; 1994 Jun; 24(25):18. PubMed ID: 10134465 [No Abstract] [Full Text] [Related]
11. Lowering the cost of prescription drugs. Jindal B J La State Med Soc; 2003; 155(1):51. PubMed ID: 12656276 [No Abstract] [Full Text] [Related]
12. Controlling the cost of prescription drugs. White JR Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498 [No Abstract] [Full Text] [Related]
13. Health care reform: pharmaceutical industry sees itself as 'whipping boy'. Gatty B Hosp Formul; 1993 Oct; 28(10):872, 871. PubMed ID: 10129137 [No Abstract] [Full Text] [Related]
14. Clinton's breakthrough drug committee: will it stifle new drug development? Gatty B Hosp Formul; 1993 Nov; 28(11):946, 945. PubMed ID: 10130236 [No Abstract] [Full Text] [Related]
15. Pharmaceutical pricing. Health care purchasing at risk. Betz R Health Syst Rev; 1995; 28(1):21-3. PubMed ID: 10139753 [No Abstract] [Full Text] [Related]
16. How will drug and device makers fare under Clinton's reform plan? Blankenau R Mater Manag Health Care; 1993 Nov; 2(11):18, 20. PubMed ID: 10129563 [No Abstract] [Full Text] [Related]
17. Health care reform and the pharmaceutical industry. Mossinghoff GJ Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353 [TBL] [Abstract][Full Text] [Related]
18. Pryor bill to enter fray over drug costs. Weissenstein E Mod Healthc; 1992 Mar; 22(9):26. PubMed ID: 10116351 [No Abstract] [Full Text] [Related]
19. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices. Pinzone JD J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775 [No Abstract] [Full Text] [Related]
20. These doctor's mission: keeping drug costs down. Guglielmo WJ Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066 [No Abstract] [Full Text] [Related] [Next] [New Search]